Advertisement

Table of Contents

May 01, 1990; Volume 37,Issue 5

You have access
Inverse modulation of gamma-aminobutyric acid- and glycine-induced currents by progesterone.
F S Wu, T T Gibbs and D H Farb

Molecular Pharmacology May 1990, 37 (5) 597-602;
You have access
Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation.
D C Javitt, M J Frusciante and S R Zukin

Molecular Pharmacology May 1990, 37 (5) 603-607;
You have access
Stable expression of rat cytochrome P-450IA1 cDNA in V79 Chinese hamster cells and their use in mutagenicity testing.
S Dogra, J Doehmer, H Glatt, H Mölders, P Siegert, T Friedberg, A Seidel and F Oesch

Molecular Pharmacology May 1990, 37 (5) 608-613;
You have access
Solubilization of active somatostatin receptors from rat brain.
H T He, S Rens-Domiano, J M Martin, S F Law, S Borislow, M Woolkalis, D Manning and T Reisine

Molecular Pharmacology May 1990, 37 (5) 614-621;
You have access
Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
K J Ivins and P B Molinoff

Molecular Pharmacology May 1990, 37 (5) 622-630;
You have access
Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.
C Reithmann, P Gierschik, U Müller, K Werdan and K H Jakobs

Molecular Pharmacology May 1990, 37 (5) 631-638;
You have access
Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
W E Evans and M V Relling

Molecular Pharmacology May 1990, 37 (5) 639-642;
You have access
Stereoselective sulfoxidation of a series of alkyl p-tolyl sulfides by microsomal and purified flavin-containing monooxygenases.
A E Rettie, B D Bogucki, I Lim and G P Meier

Molecular Pharmacology May 1990, 37 (5) 643-651;
You have access
Differential expression of gamma-aminobutyric acidA receptor subunits.
K M Garrett, N Saito, R S Duman, M S Abel, R A Ashton, S Fujimori, B Beer, J F Tallman, M P Vitek and A J Blume

Molecular Pharmacology May 1990, 37 (5) 652-657;
You have access
Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
E De Clercq, R Bernaerts, A Merta and B Rosenwirth

Molecular Pharmacology May 1990, 37 (5) 658-664;
You have access
Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
A Fridland, M C Connelly and R Ashmun

Molecular Pharmacology May 1990, 37 (5) 665-670;
You have access
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
D H Maurice and R J Haslam

Molecular Pharmacology May 1990, 37 (5) 671-681;
You have access
Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.
E B Haddad, Y Landry and J P Gies

Molecular Pharmacology May 1990, 37 (5) 682-688;
You have access
Specific binding sites for inositolhexakisphosphate in brain and anterior pituitary.
F Nicoletti, V Bruno, S Cavallaro, A Copani, M A Sortino and P L Canonico

Molecular Pharmacology May 1990, 37 (5) 689-693;
You have access
Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
M Tiberi and J Magnan

Molecular Pharmacology May 1990, 37 (5) 694-703;
You have access
Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
R Brodersen, N Jørgensen, H Vorum and N Krukow

Molecular Pharmacology May 1990, 37 (5) 704-709;
You have access
gamma-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines.
D J Roca, G D Schiller, L Friedman, I Rozenberg, T T Gibbs and D H Farb

Molecular Pharmacology May 1990, 37 (5) 710-719;
You have access
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
M M White and M Aylwin

Molecular Pharmacology May 1990, 37 (5) 720-724;
You have access
Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC.
A K Ghose and G M Crippen

Molecular Pharmacology May 1990, 37 (5) 725-734;
You have access
Ryanodine as a probe for the functional state of the skeletal muscle sarcoplasmic reticulum calcium release channel.
A Chu, M Díaz-Muñoz, M J Hawkes, K Brush and S L Hamilton

Molecular Pharmacology May 1990, 37 (5) 735-741;
You have access
Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
D A Conner and T E Mansour

Molecular Pharmacology May 1990, 37 (5) 742-751;
You have access
Antipsychotic pimozide is a potent Ca2+ channel blocker in heart.
J J Enyeart, R T Dirksen, V K Sharma, D J Williford and S S Sheu

Molecular Pharmacology May 1990, 37 (5) 752-757;
You have access
Desensitization of islet cells to bombesin involves both receptor down-modulation and inhibition of receptor function.
S L Swope and A Schonbrunn

Molecular Pharmacology May 1990, 37 (5) 758-766;
You have access
Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam.
P E Reilly, D A Thompson, S R Mason and W D Hooper

Molecular Pharmacology May 1990, 37 (5) 767-774;